3 news items
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
ACXP
15 May 24
statements regarding our strategy, future operations, prospects, plans and objectives, and other statements containing the words "believes
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
ACXP
2 May 24
, plans and prospects, including statements regarding our strategy, future operations, prospects, plans and objectives, and other statements containing
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
ACXP
25 Apr 24
statements regarding our strategy, future operations, prospects, plans and objectives, and other statements containing the words "believes
- Prev
- 1
- Next